Please login to the form below

Not currently logged in
Email:
Password:

Cardioxyl appoints Novartis scientist as chief medical officer

Shi Yin Foo joins cardiovascular specialist

Cardioxyl Shi Yin Foo Cardioxyl Pharmaceuticals has appointed Novartis' Dr Shi Yin Foo as chief medical officer.

Dr Foo was responsible for the establishment and execution of multiple programmes in heart failure and the cardiorenal space at Novartis and will use her experience to lead research at US-based cardiovascular specialist Cardioxyl.

This experience includes time as a clinical and translational medicine reviewer for numerous studies from phase I to phase III clinical trials.

“Her unique combination of both early- and late-stage cardiovascular development experience combined with her extensive clinical experience in the treatment of patients with heart failure will serve as an excellent complement to Cardioxyl's proprietary expertise in the biology, physiology and chemistry of nitroxyl donors," said Dr Chris Kroeger, Cardioxyl's president and CEO.

Dr Foo spent four years at Novartis from 2009 have joined the pharma company from her role as a physician at Massachusetts General Hospital in the US, where she specialised in cardiology.

16th September 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics